Journal of Young Pharmacists logo
Article

Protective Action of Flavonoids Genistein and Gingerol against Cisplatin Toxicity In vitro

1,2★, 1, 1★ Corresponding author

  1. 1Human Genetics and Toxicology Laboratory, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh, Uttar Pradesh, INDIA.
  2. 2Biology Department, Jazan University, Jazan, SAUDI ARABIA.

CORRESPONDENCE

Beg T

Human Genetics and Toxicology Laboratory, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh, Uttar Pradesh, INDIA.

tan.beg@gmail.com

Volume 4, Issue 2 · pp. 124-125 · 2012 · DOI: 10.4103/0975-1483.96628

ABSTRACT

Sir, Cisplatin is a platinum-based chemotherapy drug used for treating cancers and has proved to be toxic in earlier studies. Cisplatin has a number of side effects that can limit its usage. Many agents have been shown to ameliorate cisplatin toxicity. Genistein is an antioxidant isoflavone found in many plants as well as animal cells, soybeans, and soy products being a major source. Gingerol is the active constituent of fresh ginger and a proven antioxidant. Genistein and gingerol have been reported for their antigenotoxic and antimutagenic potential in cultured human lymphocytes. The earlier reported toxicity of cisplatin, the antimutagenic action of genistein and gingerol, provided the basis for this study in the presence of metabolic activation to assess the effective dose level.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    T, B., YH, S., & M, A. (2012). Protective Action of Flavonoids Genistein and Gingerol against Cisplatin Toxicity In vitro. Journal of Young Pharmacists, 4(2), 124-125. https://doi.org/10.4103/0975-1483.96628

    Copyright and licence

    © 2012 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0